The metabolic phenotype of Prader-Willi syndrome (PWS) in childhood: Heightened insulin sensitivity relative to body mass index

Journal of Clinical Endocrinology and Metabolism

Volumn 96, Issue 1, 2011, Pages

  Haqq, Andrea M ^a   Muehlbauer, Michael J ^b   Newgard, Christopher B ^b   Grambow, Steven ^c   Freemark, Michael ^b  

^a UNIVERSITY OF ALBERTA   (Canada)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c DURHAM VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; C REACTIVE PROTEIN; GLUCAGON LIKE PEPTIDE 1; GLUCOSE; HIGH DENSITY LIPOPROTEIN; INSULIN; INTERLEUKIN 10; INTERLEUKIN 12P40; INTERLEUKIN 18; INTERLEUKIN 2; INTERLEUKIN 6; INTERLEUKIN 8; LEPTIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MONOCYTE CHEMOTACTIC PROTEIN; RESISTIN; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BODY MASS; CHILD; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; GLUCOSE BLOOD LEVEL; HOMEOSTASIS; HORMONE BLOOD LEVEL; HUMAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPOPROTEIN BLOOD LEVEL; LIVER FUNCTION TEST; MALE; OBESITY; PHENOTYPE; PRADER WILLI SYNDROME; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SCHOOL CHILD; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 78650885904     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2010-1733     Document Type: Article

References (40)

1. Bray GA, Dahms WT, Swerdloff RS, Fiser RH, Atkinson RL, Carrel RE 1983 The Prader-Willi syndrome: a study of 40 patients and a review of the literature. Medicine (Baltimore) 62:59-80 (Pubitemid 13113779)
2. Runte M, Hüttenhofer A, Gross S, Kiefmann M, Horsthemke B, Buiting K 2001 The IC-SNURF-SNRPN transcript serves as a host for multiple small nucleolar RNA species and as an antisense RNA for UBE3A. Hum Mol Genet 10:2687-2700
3. Muscatelli F, Abrous DN, Massacrier A, Boccaccio I, Le Moal M, Cau P, Cremer H 2000 Disruption of the mouse Necdin gene results in hypothalamic and behavioral alterations reminiscent of the human Prader-Willi syndrome. Hum Mol Genet 9:3101-3110
4. Mercer RE, Kwolek EM, Bischof JM, van Eede M, Henkelman RM, Wevrick R 2009 Regionally reduced brain volume, altered serotonin neurochemistry, and abnormal behavior in mice null for the circadian rhythm output gene Magel2. Am J Med Genet B Neuropsychiatr Genet 150B:1085-1099
5. Lindgren AC, Hagenäs L, Ritzén EM 1999 Growth hormone treatment of children with Prader-Willi syndrome: effects on glucose and insulin homeostasis. Swedish National Growth Hormone Advisory Group. Horm Res 51:157-161
6. Schuster DP, Osei K, Zipf WB 1996 Characterization of alterations in glucose and insulin metabolism in Prader-Willi subjects. Metabolism 45:1514-1520
7. Haqq AM, Muehlbauer M, Svetkey LP, Newgard CB, Purnell JQ, Grambow SC, Freemark MS 2007 Altered distribution of adiponectin isoforms in children with Prader-Willi syndrome (PWS): association with insulin sensitivity and circulating satiety peptide hormones. Clin Endocrinol (Oxf) 67:944-951
8. Zipf WB, O'Dorisio TM, Cataland S, Dixon K 1983 Pancreatic polypeptide responses to protein meal challenges in obese but otherwise normal children and obese children with Prader-Willi syndrome. J Clin Endocrinol Metab 57:1074-1080
9. Sareen C, Ruvalcaba RH, Kelley VC 1975 Some aspects of carbohydrate metabolism in Prader-Willi syndrome. J Ment Defic Res 19:113-119
10. Goldstone AP, Thomas EL, Brynes AE, Bell JD, Frost G, Saeed N, Hajnal JV, Howard JK, Holland A, Bloom SR 2001 Visceral adipose tissue and metabolic complications of obesity are reduced in Prader-Willi syndrome female adults: evidence for novel influences on body fat distribution. J Clin Endocrinol Metab 86:4330-4338
11. Kennedy L, Bittel DC, Kibiryeva N, Kalra SP, Torto R, Butler MG 2006 Circulating adiponectin levels, body composition and obesity-related variables in Prader-Willi syndrome: comparison with obese subjects. Int J Obes 30:382-387
12. Festen DA, van Toorenenbergen A, Duivenvoorden HJ, Hokken-Koelega AC 2007 Adiponectin levels in prepubertal children with Prader-Willi syndrome before and during growth hormone therapy. J Clin Endocrinol Metab 92:1549-1554
13. Haqq AM, Grambow SC, Muehlbauer M, Newgard CB, Svetkey LP, Carrel AL, Yanovski JA, Purnell JQ, Freemark M 2008 Ghrelin concentrations in Prader-Willi syndrome (PWS) infants and children: changes during development. Clin Endocrinol (Oxf) 69:911-920
14. Joo EY, Hong SB, Sohn YB, Kwak MJ, Kim SJ, Choi YO, Kim SW, Paik KH, Jin DK 2010 Plasma adiponectin level and sleep structures in children with Prader-Willi syndrome. J Sleep Res 19:248-254
15. Hotamisligil GS 2006 Inflammation and metabolic disorders. Nature 444:860-867
16. Gupta A, Ten S, Anhalt H 2005 Serum levels of soluble tumor necrosis factor-α receptor 2 are linked to insulin resistance and glucose intolerance in children. J Pediatr Endocrinol Metab 18:75-82
17. Krochik AG, Ozuna B, Torrado M, Chertkoff L, Mazza C 2006 Characterization of alterations in carbohydrate metabolism in children with Prader-Willi syndrome. J Pediatr Endocrinol Metab 19:911-918
18. Eiholzer U, Stutz K, Weinmann C, Torresani T, Molinari L, Prader A 1998 Low insulin, IGF-I and IGFBP-3 levels in children with Prader-Labhart-Willi syndrome. Eur J Pediatr 157:890-893
19. Talebizadeh Z, Butler MG 2005 Insulin resistance and obesity-related factors in Prader-Willi syndrome: comparison with obese subjects. Clin Genet 67:230-239
20. Sohn YB, Kwak MJ, Kim SJ, Park SW, Kim CH, Kim MY, Kwon EK, Paik KH, Jin DK 2010 Correlation of adiponectin receptor expression with cytokines and insulin sensitivity in growth hormone (GH)-treated children with Prader-Willi syndrome and in non-GH-treated obese children. J Clin Endocrinol Metab 95:1371-1377
21. Eiholzer U, L'allemand D, Schlumpf M, Rousson V, Gasser T, Fusch C2004 Growth hormone and body composition in children younger than 2 years with Prader-Willi syndrome. J Pediatr 144:753-758
22. Eiholzer U, Blum WF, Molinari L 1999 Body fat determined by skinfold measurements is elevated despite underweight in infants with Prader-Labhart-Willi syndrome. J Pediatr 134:222-225
23. Bacha F, Saad R, Gungor N, Arslanian SA 2004 Adiponectin in youth: relationship to visceral adiposity, insulin sensitivity, and β-cell function. Diabetes Care 27:547-552
24. Jeffery AN, Murphy MJ, Metcalf BS, Hosking J, Voss LD, English P, Sattar N, Wilkin TJ 2008 Adiponectin in childhood. Int J Pediatr Obes 3:130-140
25. Berntson GG, Zipf WB, O'Dorisio TM, Hoffman JA, Chance RE 1993 Pancreatic polypeptide infusions reduce food intake in Prader-Willi syndrome. Peptides 14:497-503
26. Höybye C, Bruun JM, Richelsen B, Flyvbjerg A, Frystyk J 2004 Serum adiponectin levels in adults with Prader-Willi syndrome are independent of anthropometrical parameters and do not change with GH treatment. Eur J Endocrinol 151:457-461
27. Caixàs A, Giménez-Palop O, Giménez-Pérez G, Potau N, Berlanga E, González-Glemente JM, Arroyo J, Laferrère B, Mauricio D 2006 Postprandial adiponectin levels are unlikely to contribute to the pathogenesis of obesity in Prader-Willi syndrome. Horm Res 65:39-45
28. Kelly AS, Steinberger J, Kaiser DR, Olson TP, Bank AJ, Dengel DR 2006 Oxidative stress and adverse adipokine profile characterize the metabolic syndrome in children. J Cardiometab Syndr 1:248-252
29. Hamsten A 1995 Hemostatic function and coronary artery disease. N Engl J Med 332:677-678
30. Bastelica D, Mavri A, Verdierl M, Berthet B, Juhan-Vague I, Alessi MC 2002 Relationships between fibrinolytic and inflammatory parameters in human adipose tissue: strong contribution of TNFα receptors to PAI-1 levels. Thromb Haemost 88:481-487
31. Alessi MC, Bastelica D, Mavri A, Morange P, Berthet B, Grino M, Juhan-Vague I 2003 Plasma PAI-1 levels are more strongly related to liver steatosis than to adipose tissue accumulation. Arterioscler Thromb Vasc Biol 23:1262-1268
32. Shimomura I, Funahashi T, Takahashi M, Maeda K, Kotani K, Nakamura T, Yamashita S, Miura M, Fukuda Y, Takemura K, Tokunaga K, Matsuzawa Y 1996 Enhanced expression of PAI-1 in visceral fat: possible contributor to vascular disease in obesity. Nat Med 2:800-803
33. Janand-Delenne B, Chagnaud C, Raccah D, Alessi MC, Juhan-Vague I, Vague P 1998 Visceral fat as a main determinant of plasminogen activator inhibitor 1 level in women. Int J Obes Relat Metab Disord 22:312-317
34. Eriksson P, Van Harmelen V, Hoffstedt J, Lundquist P, Vidal H, Stemme V, Hamsten A, Arner P, Reynisdottir S 2000 Regional variation in plasminogen activator inhibitor-1 expression in adipose tissue from obese individuals. Thromb Haemost 83:545-548 (Pubitemid 30201128)
35. Viardot A, Sze L, Purtell L, Sainsbury A, Loughnan G, Smith E, Herzog H, Steinbeck K, Campbell LV 2010 Prader-Willi syndrome is associated with activation of the innate immune system independently of central adiposity and insulin resistance. J Clin Endocrinol Metab 95:3392-3399
36. Höybye C 2006 Inflammatory markers in adults with Prader-Willi syndrome before and during 12 months growth hormone treatment. Horm Res 66:27-32
37. Caixàs A, Giménez-Palop O, Broch M, Vilardell C, Megía A, Simón I, Giménez-Pérez G, Mauricio D, Vendrell J, Richart C, González-Clemente JM 2008 Adult subjects with Prader-Willi syndrome show more low-grade systemic inflammation than matched obese subjects. J Endocrinol Invest 31:169-175
38. Laaksonen DE, Niskanen L, Punnonen K, Nyyssönen K, Tuomainen TP, Salonen R, Rauramaa R, Salonen JT 2003 Sex hormones, inflammation and the metabolic syndrome: a population-based study. Eur J Endocrinol 149:601-608
39. Einfeld SL, Kavanagh SJ, Smith A, Evans EJ, Tonge BJ, Taffe J 2006 Mortality in Prader-Willi syndrome. Am J Ment Retard 111:193-198
40. Carpenter PK 1994 Prader-Willi syndrome in old age. J Intellect Disabil Res 38(Pt 5):529-531